Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,821 to 1,840 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma. | Front Immunol | 2019 | 31231360 | PubTator, text mining | PubMed |
| BioTarget: A Computational Framework Identifying Cancer Type Specific Transcriptional Targets of Immune Response Pathways. | Sci Rep | 2019 | 31227749 | PubTator, text mining | PubMed |
| A cell topography-based mechanism for ligand discrimination by the T cell receptor. | Proc Natl Acad Sci U S A | 2019 | 31221762 | PubTator, text mining | PubMed |
| Effects of Veratrilla baillonii Extract on Hepatic Gene Expression Profiles in Response to Aconitum brachypodum-Induced Liver Toxicity in Mice. | Front Pharmacol | 2019 | 31214025 | PubTator, text mining | PubMed |
| CD48 is a key molecule of immunomodulation affecting prognosis in glioma. | Onco Targets Ther | 2019 | 31213836 | PubTator, text mining | PubMed |
| Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod. | Sci Rep | 2019 | 31189943 | PubTator, text mining | PubMed |
| Pemetrexed-induced Interstitial Lung Disease Mimicking Hypersensitivity Pneumonia: A Pathologically Proven Case. | Intern Med | 2019 | 31178492 | PubTator, text mining | PubMed |
| The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review. | Transl Oncol | 2019 | 31176993 | PubTator, text mining | PubMed |
| Scleromyxedematous Changes in a Patient With Long-Standing Mycosis Fungoides Who Progressed to Sézary Syndrome. | Am J Dermatopathol | 2019 | 31169525 | PubTator, text mining | PubMed |
| Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell. | Ann Rheum Dis | 2019 | 31167762 | PubTator, text mining | PubMed |
| LncRNA H19 regulates PI3K-Akt signal pathway by functioning as a ceRNA and predicts poor prognosis in colorectal cancer: integrative analysis of dysregulated ncRNA-associated ceRNA network. | Cancer Cell Int | 2019 | 31164794 | PubTator, text mining | PubMed |
| The "Utility" of Highly Toxic Marine-Sourced Compounds. | Mar Drugs | 2019 | 31159276 | PubTator, text mining | PubMed |
| Cynomolgus macaque IL37 polymorphism and control of SIV infection. | Sci Rep | 2019 | 31138840 | PubTator, text mining | PubMed |
| Synergy of Interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases. | Cytokine Growth Factor Rev | 2019 | 31126874 | PubTator, text mining | PubMed |
| Identification of portal vein tumor thrombus with an independent clonal origin in hepatocellular carcinoma via multi-omics data analysis. | Cancer Biol Med | 2019 | 31119055 | PubTator, text mining | PubMed |
| Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myeloma. | Int J Hematol | 2019 | 31115879 | PubTator, text mining | PubMed |
| Diffuse alveolar hemorrhage caused by IgA deposition associated with multiple myeloma. | Clin Case Rep | 2019 | 31110743 | PubTator, text mining | PubMed |
| The Potential Effect of Different Doses of Ionizing Radiation on Genes and Disease. | Dose Response | 2019 | 31105480 | PubTator, text mining | PubMed |
| 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies. | J Hematol Oncol | 2019 | 31097020 | PubTator, text mining | PubMed |
| Immunotherapeutics in Multiple Myeloma: How Can Translational Mouse Models Help? | J Oncol | 2019 | 31093282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=92